SCHEMBL21131963

SCHEMBL21131963

CS(=O)(=O)OCCNCCO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.46
ALDH1A1 P00352 5/20 0.46
ALOX15 P16050 2/20 0.46
USP2 O75604 2/20 0.46
LMNA P02545 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MMP9 P14780 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.33
HTT P42858 1/20 0.33
TP53 P04637 2/20 0.33
HTR1D P28221 1/20 0.32
HTR1B P28222 1/20 0.32
HSD17B10 Q99714 1/20 0.31
CA2 P00918 1/20 0.31
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethanolamine SCHEMBL21596422 0.78 CA2 (0.42) TSHRALDH1A1ALOX15USP2LMNA
Diethanolamine SCHEMBL1829927 0.78 CA2 (0.42) TSHRALDH1A1ALOX15USP2LMNA
SCHEMBL13661632 0.77 TSHR (0.50) TSHRALDH1A1ALOX15USP2LMNA
SCHEMBL302015 0.76
Improsulfan SCHEMBL27654142 0.76 TSHR (0.61) TSHRALDH1A1ALOX15USP2LMNA
SCHEMBL14421027 0.76 TSHR (0.48) TSHRALDH1A1ALOX15USP2LMNA
Ritrosulfan SCHEMBL297132 0.75 KDM4E (0.43) TSHRALDH1A1ALOX15USP2LMNA
Improsulfan SCHEMBL8954 0.75 USP2 (0.67) TSHRALDH1A1ALOX15USP2LMNA
SCHEMBL13661165 0.74 ALDH1A1 (0.46) TSHRALDH1A1ALOX15USP2LMNA
Ammonia Solution, Strong SCHEMBL7783978 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190185413-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF QUADRIGA BIOSCIENCES, INC. 2019-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190185413-A1 BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF SLC3A2, SLC7A1, SLC43A1 TSHR 3383/4885ALDH1A1 501/4885ALOX15 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.